COMMUNIQUÉS West-GlobeNewswire

Ohr Pharmaceutical Urges Stockholders to Vote “FOR” Merger with NeuBase Therapeutics at Special Meeting on July 10, 2019
03/07/2019
-- Of the Votes Received to Date, More than 99% Are Voting in Favor of the Merger Proposal -- More Votes Are Needed to Reach 50% of the Outstanding Shares to Go Forward with the Special Meeting -- Every Vote Is [...]
DRAFT RESOLUTIONS of Extraordinary General Meeting of Shareholders of joint stock company “Grindeks” to be held on 17 July 2019
03/07/2019
Referring to the previously announced that the mandatory share repurchase offer will not affect Board’s view in paying dividends and the overall development of the “Grindeks” Group currently indicates its ability to [...]
INmune Bio Co-Founder and CEO Presents at Maxim Group’s Conference on Alzheimer’s Disease
03/07/2019
LA JOLLA, Calif., July 03, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announced [...]
Philips ships two-millionth AED, helping to save lives across the globe
03/07/2019
July 3, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced shipment of its two-millionth AED (Automated External Defibrillator), which was [...]
OrthoPediatrics Corp. to Sponsor 26th Annual International Meeting on Advanced Spine Techniques (IMAST)
03/07/2019
WARSAW, Ind., July 03, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it will continue [...]
Auris Medical Completes Enrollment of Phase 1b Proof-Of-Concept Trial of AM-201 in Antipsychotic-Induced Weight Gain
03/07/2019
Hamilton, Bermuda, July 03, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and [...]
Zosano Pharma Announces Keynote Speech at the Pharmaceutics & Advanced Drug Delivery Systems Conference
03/07/2019
FREMONT, Calif., July 03, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that Hayley Lewis, senior vice president of operations at Zosano [...]
PDS Biotechnology Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/07/2019
BERKELEY HEIGHTS, N.J., July 03, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional [...]
Ziopharm Oncology Names NCI’s Dr. Drew Deniger to Direct TCR-T Cell Therapy Program
03/07/2019
– Dr. Deniger joins from National Cancer Institute to lead Ziopharm’s non-viral T-cell program targeting neoantigens for personalized immunotherapy of solid tumors – BOSTON, July 03, 2019 (GLOBE NEWSWIRE) -- Ziopharm [...]
REPEAT - AgraFlora Organics Awarded Health Canada Hemp Production License; To Immediately Stream High CBD Cultivars to Edibles and Beverage Manufacturing Asset Portfolio
03/07/2019
VANCOUVER, British Columbia, July 03, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
The Yogen Früz Brain Project encourages Canadians to get a ”head start” on brain health
03/07/2019
The Baycrest Foundation connects artists, celebrities and researchers to “change the future of brain health” TORONTO, July 03, 2019 (GLOBE NEWSWIRE) -- The Yogen Früz Brain Project returns for a fourth year with a [...]
Kohlberg & Company acquiert Nelipak® Healthcare Packaging
03/07/2019
CRANSTON, Rhode Island, 03 juill. 2019 (GLOBE NEWSWIRE) -- Nelipak® Corporation, Inc. (« Nelipak »), le plus important fournisseur d'emballages rigides personnalisés pour le secteur des produits pharmaceutiques et des [...]
T2 Biosystems Reports Granting of Inducement Awards
03/07/2019
LEXINGTON, Mass., July 03, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]
VitalHub Featured in 2019 Branham300 List of Top ICT Companies
03/07/2019
TORONTO, July 03, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce it has been featured in Branham Group’s 2019 list of top Canadian tech companies. Branham Group [...]
Information regarding the results of mandatory redemption of shares
03/07/2019
Joint Stock Company “Grindeks” hereby informs that it has received the information from its shareholder “Liplat Holding” Ltd. regarding the results of mandatory redemption of shares. After execution of the mandatory [...]
La coentreprise Emerald Health Therapeutics lance au Canada un supplément de santé sans cannabis soutenant le système endocannabinoïde
03/07/2019
La gamme de produits Endo est disponible dans plus de 200 magasins de produits de santé naturels VANCOUVER, Colombie-Britannique, 03 juill. 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV [...]
BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/07/2019
RESEARCH TRIANGLE PARK, N.C., July 03, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted three newly-hired [...]
Precision Biomonitoring and AgriSeq Solutions Announce Strategic Partnership in Genomics
03/07/2019
Joint efforts to help industry and public organizations quickly and accurately identify organisms and advance plant and animal breeding programs GUELPH, Ontario, July 03, 2019 (GLOBE NEWSWIRE) -- Precision Biomonitoring [...]
Algernon Pharmaceuticals’ NP-120 Reduced Fibrosis in an Idiopathic Pulmonary Fibrosis Study by 56% Outperforming USFDA Approved Treatments Nintedanib and Pirfenidone
03/07/2019
Algernon to seek a USFDA Orphan Drug Designation VANCOUVER, British Columbia, July 03, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), [...]

Pages